Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06003023 · ClinicalTrials.gov registry record · NA
Congenital Heart Disease Physical Activity Lifestyle Study V.2
A NA study of Heart Defects, Congenital and Cardiovascular Disease Other, sponsored by Jamie Jackson.
- Recruiting
- Registry status
- NA
- Development phase
- 144
- Enrollment target
- 1
- Study location
NCT06003023: Recruiting NA study of Heart Defects, Congenital and Cardiovascular Disease Other, sponsored by Jamie Jackson.
NCT06003023 is a NA study of Heart Defects, Congenital and Cardiovascular Disease Other that is actively recruiting participants, run by Jamie Jackson. The registered enrollment target is 144 participants, below the 348-participant average among 9 other Heart Defects, Congenital trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06003023, a NA study of Heart Defects, Congenital and Cardiovascular Disease Other, is actively recruiting participants, sponsored by Jamie Jackson.
- RECRUITING
- Registry status
- NA
- Development phase
- 144 participants
- Enrollment target
- 1
- Study location
Study Summary
The Congenital Heart Disease Physical Activity Lifestyle Intervention Study (CHD-PALS) V.2 seeks to determine the efficacy of a lifestyle intervention program for adolescents and young adults (AYAs) with congenital heart disease (CHD). This trial was adapted from the original CHD-PAL trial to continue improving cardiovascular outcomes for transition-aged CHD survivors.
Primary Outcome
Number of minutes spent in moderate to vigorous physical activity as measured by an accelerometer.
Conditions Studied
Interventions
- BEHAVIORAL Physical Activity Monitoring
- BEHAVIORAL Tailored Exercise Prescription
- BEHAVIORAL Healthy Lifestyle Education
- BEHAVIORAL Physical Activity Lifestyle Intervention Informed by the Theory of Planned Behavior
Study Locations (1)
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2023-07-18 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What NCT06003023 shows while recruiting
NCT06003023 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, below the 348-participant average among 9 other Heart Defects, Congenital trials with a reported enrollment target (59% lower).
The record links to 2 conditions, with Heart Defects, Congenital appearing as the primary indexed condition, and to 4 interventions - of which Physical Activity Monitoring is the first listed.
NCT06003023 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06003023 about?
NCT06003023 is a clinical study titled "Congenital Heart Disease Physical Activity Lifestyle Study V.2". The Congenital Heart Disease Physical Activity Lifestyle Intervention Study (CHD-PALS) V.2 seeks to determine the efficacy of a lifestyle intervention program for adolescents and young adults (AYAs) with congenital heart disease (CHD). This trial was adapted from the original CHD-PAL trial to contin...
What is the current status of trial NCT06003023?
This trial is currently recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2023-07-18. Estimated completion is 2027-06-30.
What conditions does trial NCT06003023 study?
This clinical trial studies the following conditions: Heart Defects, Congenital, Cardiovascular Disease Other.
What interventions are being tested in trial NCT06003023?
The interventions under investigation include: Physical Activity Monitoring (BEHAVIORAL), Tailored Exercise Prescription (BEHAVIORAL), Healthy Lifestyle Education (BEHAVIORAL), Physical Activity Lifestyle Intervention Informed by the Theory of Planned Behavior (BEHAVIORAL).
Who is sponsoring clinical trial NCT06003023?
This trial is sponsored by Jamie Jackson, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06003023 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Defects, Congenital
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06003023's enrollment target sits among peer trials
144 4th of 9 higher than 6 of 9 other Heart Defects, Congenital trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Defects, Congenital trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HeartGPS: A Study Exploring the Effects of a Psychological Intervention for Parents and Their Babies After Prenatal Cardiac Diagnosis
RECRUITING · NA
-
Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD
ACTIVE NOT RECRUITING · NA
-
Evaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction
ACTIVE NOT RECRUITING · NA
-
Tuning in to Kids: An Online, Group Program Tailored for Parents of Children With Congenital Heart Disease
COMPLETED · NA
-
SPECS: Safe Pediatric Euglycemia in Cardiac Surgery
COMPLETED · NA
-
Parent Communication for Feeding an Infant With a Heart Defect
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI